HHS sends interim peptide access policy to White House for review
The Department of Health and Human Services sent a peptide "interim access policy" to the White House for review, seeking temporary allowance for compounding pharmacies to make certain peptides. The move follows an advisor panel vote to loosen restrictions on six peptides that FDA staff deemed insufficiently studied. The policy now awaits Office of Management and Budget review.
Where this came from. 6 outlets reported this. We read them, then wrote the sixty words above.